|
Volumn 24, Issue 5 SUPPL. 15, 1997, Pages
|
Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: A multicenter French groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study
a a a a a a a a a a a a a a
a
HÔTEL DIEU
(France)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBOPLATIN;
GRANULOCYTE COLONY STIMULATING FACTOR;
PACLITAXEL;
ADULT;
AGED;
ALOPECIA;
AREA UNDER THE CURVE;
BONE MARROW SUPPRESSION;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONCENTRATION RESPONSE;
CONFERENCE PAPER;
DRUG CLEARANCE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HISTOPATHOLOGY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
INTRAVENOUS DRUG ADMINISTRATION;
MULTICENTER STUDY;
NEUTROPENIA;
OVARY CARCINOMA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
ADOLESCENT;
ADULT;
AGED;
ALOPECIA;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
AREA UNDER CURVE;
CARBOPLATIN;
CARCINOMA;
CISPLATIN;
CONFIDENCE INTERVALS;
DISEASE PROGRESSION;
FEMALE;
FRANCE;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HUMANS;
INJECTIONS, INTRAVENOUS;
MIDDLE AGED;
NAUSEA;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
NEUTROPENIA;
OVARIAN NEOPLASMS;
PACLITAXEL;
PERIPHERAL NERVOUS SYSTEM DISEASES;
REMISSION INDUCTION;
SAFETY;
SURVIVAL RATE;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
|
EID: 18244431102
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (10)
|
References (24)
|